Skip to main content
SpringerLink
Log in

Psychopharmakotherapie

  • Chapter
Handbuch der Gerontopsychiatrie

  • 72 Accesses

Zusammenfassung

Die Behandlung älterer Menschen mit Psychopharmaka ist allgemein mit folgenden Schwierigkeiten konfrontiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Addonizio G (1987) Neuroleptic malignant syndrome in elderly patients. J Am Ger Soc 35: 1011–1012

    CAS  Google Scholar 

  • Agnolia A et al (1988) Randomized doube-blind study of flunarizin versus placebo in patients with chronic cerebrovascular disorders. Int J Clin Pharmacol Res 3: 189–197

    Google Scholar 

  • Alexopoulos GS (1992) Treatment of depression. In: Salzman C (ed) Clinical geriatric psycho-pharmacology, 2nd edn. Williams & Wilkins, Baltimore, Tokyo, pp 137–174

    Google Scholar 

  • Herrmann WM, Kern U (1987) Nootropica: Wirkungen und Wirksamkeit. Eine Überlegung am Beispiel einer Phase III-Prüfung mit Piracetam. Nervenarzt 58: 358–364

    PubMed  CAS  Google Scholar 

  • Amrein R (1992) Interactions of moclobemide with concomitantly administered medication: evidence form pharmacological and clinical studies. Psychopharmacology 106 [Suppl]: 24–31

    Google Scholar 

  • Angst J, Stabl M (1992) Efficacy of moclobemid in different patient groups: a meta-analysis of studies. Psychopharmacology (Berl) 106 [Suppl]: 109–113

    Google Scholar 

  • Bannister SJ et al (1989) Evaluation of the potential of the interactions of paroxetine with diazepam, Cimetidine, warfarin and digoxin. Acta Psychiatr Scand 80 [Suppl 350]: 102–106

    Google Scholar 

  • Barnes R, Veith R, Okimoto J (1982) Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am J Psychiatry 139: 1170–1174

    PubMed  CAS  Google Scholar 

  • Beasley CM et al (1991) Fluoxetine and suicide: a metaanalysis of controlled trials of treatment of depression. Br Med J 303: 685–692

    Google Scholar 

  • Beckmann H (1983) Therapie mit nicht-trizyklischen Antidepressiva. In: Langer G, Heimann H (Hrsg) Psychopharmaka: Grundlagen und Therapie. Springer, Wien New York, S 140–159

    Google Scholar 

  • Benfeld P, Ward A (1986) Fluvoxamine. A review of ist pharmadynamic and pharmakocokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32: 313–334

    Google Scholar 

  • Bergstrom RF, Peyton AL, Lemberger L (1992) Quantification and mechanism of fluoxetine and tricyclic antidepressant interaction. Clin Pharmacol The 51: 239–248

    CAS  Google Scholar 

  • Berntmann L, Siesjö BK (1978) Brain energy metabolism and circulation in hypoxia. Proc Eu-rop Soc Neurochem 1: 253–326

    Google Scholar 

  • Bittles AH (1991) Biological aspects of ageing. In: Jacoby R, Oppenteimer C (eds) Psychiatry in the elderly. Oxford University Press, Oxford New York Tokyo, pp 3–34

    Google Scholar 

  • Blaha L (1978) Behandlungsprobleme in der Gerontopsychiatrie In: Flügel KA (ed) Neurologische und psychiatrische Therapie. Peri-med, Erlangen, S 397–402

    Google Scholar 

  • Blazer HG et al (1983) The risk of anticholinergic toxicity in the elderly: a study prescribing practices in two populations. J Gerontol 38: 31–35

    PubMed  Google Scholar 

  • Boakes AJ, Lauwrence DR, Teoh PC (1973) Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J 1: 311–315

    PubMed  CAS  Google Scholar 

  • Bohm C et al (1990) Buspirone therapy in anxious elderly patients: a controlled clinical trial. J Clin Psychopharmacology 10 [Suppl 31]: 47–51

    Google Scholar 

  • Bouchard RH, Pourcher E, Vincent P (1989) Fluoxetine and extrapyramidal side effects. Am J Psychiatry 146: 352–1353

    Google Scholar 

  • Boyer WF, Feighner JP (1991) Side effects of the selective serotonin re-uptake inhibitors. In: Feighner JP, Boyer WF (eds) Perspectives in psychiatry, vol 1. Selective serotonin reuptake inhibitors. Wiley, Chichester, pp 133–152

    Google Scholar 

  • Boyer WF, Feighner JP (1991) Pharmacokinetics and drug interactions. In: Feighner JP, Boyer WF (eds) Perspectives in psychiatry, vol 1. Selective serotonin re-uptake inhibitors. Wiley, Chichester, pp 81–88

    Google Scholar 

  • Bressler R, Katz MD (1993) Drug therapy for geriatric depression. Drugs Aging 3: 195–219

    PubMed  CAS  Google Scholar 

  • Briantr RH, Reid JL, Dollery CT (1973) Interaction between Clonidine and desipramine in man. Br Med J 1: 522–523

    Google Scholar 

  • Brosen K, Skjelbo E (1991) Fluoxetine and nor-fluoxetine are potent inhibitors of P450IID6, the source of sparteine/debrisoquine oxidation polymorphism. Br J Clin Pharmacol 32: 136–137

    PubMed  CAS  Google Scholar 

  • Brosen K, Gram LF, Kragh-Sorenson P (1991) Extremly slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine and mephenytoin. Ther Drug Monit 13: 177–182

    PubMed  CAS  Google Scholar 

  • Brown CS et al (1990) Possible influence of carba-mazepine on plasma imipramine concentration in children with attention-deficit hyperactivity disorder. J Clin Psychopharmacol 10: 359–362

    PubMed  CAS  Google Scholar 

  • Brown K et al (1993) Overdose of risperidone. Ann Emerg Med 22: 1908–1910

    PubMed  CAS  Google Scholar 

  • Burrows GD et al (1979) Effects of mianserin on cardiac condition. Med J Aust 2: 97–98

    PubMed  CAS  Google Scholar 

  • Campbell AJ (1991) Drug treatment as a cause of falls in old age. A review ofthe offending agents. Drugs Aging 1: 289–302

    PubMed  CAS  Google Scholar 

  • Casey DA (1994) Depression in the elderly. South Med J 87: 559–563

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Barnhill JG, Jaffe JH (1988) Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers. Clin Pharmaol Ther 43: 509

    CAS  Google Scholar 

  • Closser MH (1991) Benzodiazepines and the elderly. A review of potential problems. J Subst Abuse Treat 8: 35–41

    PubMed  CAS  Google Scholar 

  • Cohen LJ (1994) Risperidone. Pharmacotherapy 14: 253–265

    PubMed  CAS  Google Scholar 

  • Cooper SM et al (1989) The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam or alcohol. Acta Psychiatr Scand 80: 53–55

    Google Scholar 

  • Coper H, Kanowski S (1983) Nootropika: Grundlagen und Therapie In: Langer G, Heimann H (eds) Pychopharmaka-Grundlagen und Therapie. Springer, Wien New York, S 409–433

    Google Scholar 

  • Crewe HK et al (1991) The effect of paroxetine and other specific serotonin re-uptake inhibitors on cytochrome P450IID6 activity in human liver microsomes. Br J Clin Pharmacol 32: 658–659

    Google Scholar 

  • Dawson ME, Schell AM, Catanca JJ (1977) Autonomic correlates of depression and clinical Improvementf ollowing electroconvulsive shock therapy. Psychophysiology 14: 569–578

    PubMed  CAS  Google Scholar 

  • De-Vanna M et al (1990) Moclobemide compared with second-generation antidepressants in elderly people. Acta Psychiatr Scand 360 [Suppl]: 64–66

    CAS  Google Scholar 

  • Demling J et al (1993) Nicht-trizyklische Antidepressiva: Interaktionen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka. Ein Therapiehandbuch. Bd 3: Antidepressiva und Phasenprophylaktika. Springer, Wien New York, S 207–218

    Google Scholar 

  • Dewan MJ et al (1992) The use of antidepressants in the elderly: 1986 and 1989. J Geriatr Psychiatry Neurol 5: 40–44

    PubMed  CAS  Google Scholar 

  • Diamond SJ (1975) Use of a nootropic substance to increase the capacity for verbal learning and memory in normal man. In: Agnoli A (ed) Proceedings of the Symposium „Nooanaleptic and Nootropic Drugs“, 3rd Congress of the International College of Psychosomatic Median, Rome, pp 107–110

    Google Scholar 

  • Dietmaier O (1993) Trizyklische Antidepressiva: Interaktionen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuropsychoharmaka. Ein Therapiehandbuch. Bd 3: Antidepressiva und Phasenprophylaktika. Springer, Wien New York, S 72–82

    Google Scholar 

  • Dunner DL et al (1992) Two combined, multi-center doubleblind studies of paroxetine and doxepin in geriatric oatients with major depression. J Clin Psychiatry 53 [Suppl]: 57–60

    PubMed  Google Scholar 

  • Ehrly AM, Schmittner I (1976) Einfluß von Xan-tinolnicotinat auf die Fließfähigkeit von Blut in einem in vitro Kapillarsystem In: Bredin K, Gross D (Hrsg) Moderne Thromboseprophylaxe, Schattauer, Stuttgart New York, S 308–314

    Google Scholar 

  • Feighner JP et al (1983) A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive episode. Br J Clin Pharmacol 15: 227–237

    Google Scholar 

  • Feighner JP et al (1990) Adverse consequences of fluoxetine-MAOI combination therapy. J Clin Psychiatry 51: 222–225

    PubMed  CAS  Google Scholar 

  • Fischhof PK et al (1989) Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York, pp 350–359

    Google Scholar 

  • Fischhof PK et al (1990) Therapieergebnisse mit Nimodipin bei primär degenerativer Demenz und Multinfarkdemenz. 2 Geriatrie 6: 320–327

    Google Scholar 

  • Fischhof PK (1991) Vincamin bei stationären Patienten mit primär degenerativer Demenz vom Alzheimer Typ bzw Multi-Infarkt-De-menz während einer 12wöchigen Behandlungsdauer (unveröffentlicht)

    Google Scholar 

  • Fischhof PK et al (1992) Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer’s type (SDAT) and Multinfarct Dementia (MID). Neuropsychobiology 26: 65–70

    PubMed  CAS  Google Scholar 

  • Fischhof PK (1993a) Divergent neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca+2 homeostasis in dementia. Meth and Find Exptl Clin Pharmacol 8: 549–555

    Google Scholar 

  • Fischhof PK (1993b) Therapie mit Nootropika. In: Dietzel M, Dorow R, Friedmann A (eds) Psychopharmaka. 1× 1 der Psychopharmaka: Standardtherapien und neue Konzepte. Springer, Berlin Heidelberg

    Google Scholar 

  • Fitton A, Faulds D, Goa KL (1992) Moclobemide. A review of ist pharmacological properties and therapeutic use in depressive illness. Drugs 43: 561–596

    PubMed  CAS  Google Scholar 

  • Foy A et al (1995) Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci 50: 99–106

    Google Scholar 

  • Fritze J, Laux G (1993) Trizyklische Antidepressiva: unerwünschte Wirkungen, Kontraindikationen, Überdosierung, Intoxikationen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neu-ropsychopharmaka. Ein Therapiehandbuch. Bd 3: Antidepressiva und Phasenprophylaktika. Springer, Wien New York, S 59–71

    Google Scholar 

  • Giurgea C (1976) Piracetam: nootropic pharmacology of neurointegrative activity. Current Developments in Psychopharmacology, vol 3. Spectrum, New York, pp 223–273

    Google Scholar 

  • Goodwin FK, Prange AJ, Post RM (1982) Potentiation of antidepressant effect by L-trijodo-thyronine in tricyclic nonresponders. Am J Psychiatry 139: 34–38

    PubMed  CAS  Google Scholar 

  • Gram LF et al (1993) Citalopram: Interaction studies with levopromazine, imipramine, and lithium. Ther Drug Monit 15: 18–24

    PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Harmatz JS, Shader RI (1991) Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part I). Clin Pharmacokinet 21: 165–177

    PubMed  CAS  Google Scholar 

  • Grimsley SR et al (1991) Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 50: 10–15

    PubMed  CAS  Google Scholar 

  • Grundye E, Bowling A (1991) The sociology of ageing. In: Jacoby R, Oppenheimer C (eds) Psychiatry in the elderly. Oxford University Press, Oxford New York Tokyo, pp 35–57

    Google Scholar 

  • Grüter W, Pöldinger W (1982) Maprotiline. Mod Probi Pharmacopsychiatry 18: 1–30

    Google Scholar 

  • Halper JP, Mann JJ (1990) Cardiovascular effects of antidepressant medications. Brit J Psychiatry 153: 87–98

    Google Scholar 

  • Hart RP, Cclenda CC, Hamer RM (1991) Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 148: 73–77

    PubMed  CAS  Google Scholar 

  • Henauer SA, Hollister LE (1984) Cimetidine interaction with imipramine and nortriptyline. Clin Pharmacol Ther 35: 183–185

    PubMed  CAS  Google Scholar 

  • Herrmann WM, Kern U (1987) Nootropica: Wirkungen und Wirksamkeit. Eine Überlegung am Beispiel einer Phase II-Prüfung mit Piracetam. Nervenarzt 58: 358–364

    PubMed  CAS  Google Scholar 

  • Herrmann WM, Kern U, Röhmel J (1986) On the effects of pyritinol on functional deficits of patients with organic mental disorder. Phar-macopsychiatr 19: 378–385

    CAS  Google Scholar 

  • Herrschaft H (1974) Die Bedeutung regionaler Hirndurchblutung für die Diagnostik und Therapie der zerebralen Durchblutungsstörungen. 2 Therapiewoche 28: 1–10

    Google Scholar 

  • Hetzel W (1992) Neueste Angaben über die klinische Verträglichkeit von Moclobemid: Suizide, Intoxikationen und Nebenwirkungen. 3. Int. Moclobemid-Symposium, Wien, 29.-31. 3. 1992. Abstracts, S 7

    Google Scholar 

  • Hohagen F et al (1994) Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand 90: 102–108

    PubMed  CAS  Google Scholar 

  • Holzer JC, Guelman DR, Price BH (1995) Efficacy of buspirone in the treatment of dementia with aggression. Am J Psychiatry 152: 812

    PubMed  CAS  Google Scholar 

  • Janowsky DD et al (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 23: 632–635

    Google Scholar 

  • Jarvis MR (1991) Clinical pharmacokinetics of tricyclic antidepressant overdose. Psycho-pharmacol Bull 27: 541–550

    CAS  Google Scholar 

  • Jellinger K (1983) Psychopharmakatherapie beim alten Menschen. In: Langer G, Heimann H (Hrsg) Psychopharmaka: Grundlagen und Therapie. Springer, Wien New York, S 591–613

    Google Scholar 

  • Jenike MA (1985) Handbook of geriatric psycho-pharmacology. PSG Publishing, Littleton

    Google Scholar 

  • Jeste DV, Wyatt RJ (1987) Aging and tardive dyskinesia. In: Miller NE, Cohen GD (eds) Schizophrenia and aging. Guilford, New York

    Google Scholar 

  • Jori A, Annoni F, Bianchetti A (1968) Metabolic effects induced by the interaction of reserpine with desipramine. J Pharm Pharmacol 20: 862–866

    PubMed  CAS  Google Scholar 

  • Kanowski S et al (1990) Efficacy of xantinolnico-tinate in patients with dementia. Pharmako-psychiat 23: 118–124

    CAS  Google Scholar 

  • Kanowski S et al (1988) Wirksamkeitsnachweis von Nootropika am Beispiel von Nimodipin-ein Beitrag zur Entwicklung geeigneter klinischer Prüfmodelle. Z Gerontopsychol-psychiatr 1: 35–44

    Google Scholar 

  • Kirven LE, Montero EF (1973) Comparison of thioridazine and diazepam in the control of nonpsychotic symptoms associated with senility: double-blind control study. Am J Geriatr Soc 21: 545–551

    Google Scholar 

  • Klein-Schwartz W, Oderda GM (1991) Poisoning in the elderly. Epidemiological, clinical and management considerations. Drugs Aging 1: 67–89

    PubMed  CAS  Google Scholar 

  • Koch-Weser J, Sellers EM (1971) Drug interactions with coumarin anticoagulants. N Engl J Med 285: 547–558

    CAS  Google Scholar 

  • Kraus MF, Burch EA (1992) Methylphanidate hydrochloride as an antidepressant: controversy, case studies and review. South Med J 85: 985–991

    PubMed  CAS  Google Scholar 

  • Krieglstein J (1990) Hirnleistungsstörungen-Pharmakologie und Ansätze für die Therapie. Wiss. Verlagsges., Stuttgart

    Google Scholar 

  • Kruse WH (1990) Problems and pitfalls in the use of benzodiazepiens in the elderly. Drg Saf 5: 328–344

    CAS  Google Scholar 

  • Ladurner G (1991) DieTherapie des ischämischen Insultes und der chronischen zerebrovasku-lären Insuffiziens. In: Ladurner G (Hrsg) Die zerebrovaskuläre Insuffizienz. Zuckschwerdt, München, S 69–90

    Google Scholar 

  • Landauer AA, Milner G, Patman J (1969) Alcohol and amitriptyline effects on skills related to drivingbehavior. Science 63:1467

    Google Scholar 

  • Landfield PW (1989) Calcium homeostasis in brain aging and Alzheimer’s disease. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York, pp 276–287

    Google Scholar 

  • Langer G, Schönbeck G (1983) Klinische Pharmakologie der Antidepressiva. In: Langer G, Heimann H (Hrsg) Psychopharmaka: Grundlagen und Therapie. Springer, Wien New York, S 96–110

    Google Scholar 

  • Lasswell WL, Weber SS, Wilkins JM (1984) In vitro interaction of neuroleptics and tricyclic antidepressants with coffee, tea and gallotanic acid. J Pharm Sci 73: 1056–1058

    PubMed  CAS  Google Scholar 

  • Learoyd DM (1972) Toxic drug reactions in the elderly. Med J Aust I: 1131–1133

    Google Scholar 

  • Lehofer M et al (1995) Effect of Tricyclic antidepressants on cardiac vagal tone related to age (im Druck)

    Google Scholar 

  • Lemberger L et al (1988) The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam. Clin Pharmacol Ther 43: 412–419

    PubMed  CAS  Google Scholar 

  • Liljequist R, Seppala T, Mattilya MJ (1978) Amitriptyline-and mianserin-induced changes in acquisition of paired-association learning task. Br J Clin Pharmacol 5: 149–153

    PubMed  CAS  Google Scholar 

  • Linnoila M, George L, Guthrie S (1982) Interactions between antidepressants and perphenazine in psychiatric inpatients. Am J Psychiatry 139: 1329–1331

    PubMed  CAS  Google Scholar 

  • Lohner H et al (1993) Therapie von Depressionen durch Manipulation des Schlaf-Wachrhythmus. In: Peter JH et al (Hrsg) Der therapeutische Fortschritt in der Schlafmedizin. Wien Med Wochenschr 144: 26–31

    Google Scholar 

  • Lohr JB et al (1993) Treatment of disordered behavior. In: Salzman C (ed) Clinical geriatric psychopharmacology, 2nd edn. Williams & Wilkins, Baltimore Tokyo, pp 79–113

    Google Scholar 

  • Luo H, Richardson JS (1993) A pharmacological comparison of Citalopram, a bicyclic serotonin uptake inhibitor, with traditional tricyclic antidepressants. Int Clin Psychopharmacol 8: 3–12

    PubMed  CAS  Google Scholar 

  • Maczaj M (1993) Pharmacological treatment of insomnia. Drugs 45: 44–55

    PubMed  CAS  Google Scholar 

  • Maguire K, Pereira A, Tiller J (1991) Moclobemi-de pharmacokinetics in depressed patients: lack of age effect. Hum Psychopharmacol 6: 249–252

    Google Scholar 

  • McDonald RJ (1982) Drug treatment of senile dementia. In: Wheathley D (ed) Psychophar-macology of old age. Chapter 9. Oxford University Press, Oxford

    Google Scholar 

  • Mendlewicz J (1984) Acute and chronic effects of mianserin on sleep EEG architecture. Clin Neuropharmacol 7: 638–639

    Google Scholar 

  • Montgomery SA, Bullock T, Pinder RM (1991) The clinical profile of mianserin. Nord Psykiatr Tidsskr 45: 27–35

    Google Scholar 

  • Murphy JE (1978) Mianserin in the treatment of depressive illness and anxiety states in general practice. Br J Clin Pharmacol 5: 81–82

    Google Scholar 

  • Nair NPV et al (1995) Reversible and selective inhibitors of monoamine oxidase a in the treatment of depressed elderly patients. Acta Psychiatr Scand 91 [Suppl 386]: 28–35

    Google Scholar 

  • Napoliello MJ, Domantay AG (1991) Buspirone: a world-wide update. Br J Psychiatry 12 [Suppl]: 40–44

    Google Scholar 

  • NIH Consensus Development Conference Statement (1993) Diagnosis and treatment of depression in late life. Psychopharmacol Bull 29: 87–100

    Google Scholar 

  • Old Age Depression Interest Group (1993) How long should the elderly take antidepressants? A double blind placebo-controlled study of continuation/prophylaxis therapy with do-thiepin. Br J Psychiatry 162: 175–182

    Google Scholar 

  • Olson KR et al (1994) Seizures associated with poisoning and drug overdose. Am J Emerg Med 11: 565–568

    Google Scholar 

  • Owens DG (1994) Extrapyramidal side effects and tolerability of risperidone: a review. J Clin Psychiatry 55 [Suppl]: 29–35

    PubMed  Google Scholar 

  • Petor R et al (1988) Randomized trial of prophylactic daily aspirin. Br Med J 296: 313–316

    Google Scholar 

  • Peyramond A (1978) Ètude comparative croisée del’action du tiapride et du méprobamate sur les états d’agitation. Semaine des Hôpitaux 54: 542–545

    PubMed  CAS  Google Scholar 

  • Phanjoo A (1991) The elderly depressed and treatment with fluvoxamine. Int Clin Psychopharmacol 6 [Suppl 3]: 33–37

    PubMed  Google Scholar 

  • Pöch G, Juan H (1990) Wirkungen von Pharmaka. 2. neubearbeitete und erweiterte Auflage. Thieme, Stuttgart New York

    Google Scholar 

  • Pomara N et al (1984) Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentration. Psychopharma-cology 84: 342–346

    CAS  Google Scholar 

  • Postma JU, Vranesic D (1983) Moclobemide in the treatment of depression in demented geriatric patients. Arch Ther 11: 1–4

    Google Scholar 

  • Raemakers JG, Swijgman HF, O’Hanlon JF (1992) The effect of moclobemide and mianserine on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology 106 [Suppl]: 562–567

    Google Scholar 

  • Ray WA et al (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316: 363–369

    PubMed  CAS  Google Scholar 

  • Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136 (7): 873–883

    PubMed  CAS  Google Scholar 

  • Ray WA, Thapa PB, Shorr RI (1993) Medications and the older driver. Clin Geriatr Med 9: 413–438

    PubMed  CAS  Google Scholar 

  • Razani J et al (1983) The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. Arch Gen Psychiatry 40: 657–661

    PubMed  CAS  Google Scholar 

  • Regestein QR (1992) Treatment of insomnia in the elderly. In: Salzman C (ed) Clinical geriatric psychopharmacology, 2nd edn. Williams & Wilkins, Baltimore Tokyo, pp 235–253

    Google Scholar 

  • Rickels K (1990) Buspirone in clinical practice. J Clin Psychiatry 51 [Suppl]: 51–54

    PubMed  Google Scholar 

  • Rickels K, Schweizer E, Lucki I (1987) Benzodiazepine side effects. In: Psychiatryupdate: American Psychiatric association annual review, vol 6. American Psychiatric Press, Washington DC, pp 781–801

    Google Scholar 

  • Robbe HWJ, Shoenmakers EAMJ, O’Hanlon JF (1989) Acute and subchronic effects of paroxetine and amitriptyline on psychomotor and driving performance. 8th World Congress of Psychiatry, Athens

    Google Scholar 

  • Rouquet JP, Bezaury JP (1984) Traitment de l’agitation dans les états démentiels. Ètude comparative, en ouvert, de l’action du tiapride et du lorazepam. Semaine des Hôpitaux 60: 3068–3088

    Google Scholar 

  • Ryyanen OP et al (1993) Medication and chronic diseases as risk factors for falling injuries in the elderly. Scand J Soc Med 21: 264–271

    Google Scholar 

  • Salama AA, Shafey M (1989) A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate. Am J Psychiatry 146: 278

    PubMed  CAS  Google Scholar 

  • Saletu B (1986) Neurophysiologische Aspekte des normalen und pathologischen Alterns und der Gerontopharmakologie In: Lauter H, Möller HJ, Zimmer R (Hrsg) Untersuchungsund Behandlungsverfahren in der Geronto-psychiatrie. Springer, Berlin Heidelberg, S 168–188

    Google Scholar 

  • Salzman C (1990) Anxiety in the elderly: treatment strategies. J Clin Psychiatry 51 [Suppl]: 18–21

    PubMed  Google Scholar 

  • Salzman C (1992) Treatment of anxiety. In: Salzman C (ed) Clinical geriatric psychopharma-cology, 2nd edn. Williams & Wilkins, Baltimore Tokyo, pp 189–212

    Google Scholar 

  • Salzman C (1993) Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 54: 23–28

    PubMed  Google Scholar 

  • Salzman C, Shader RI, Pearlman M (1970) Psychopharmacology and the ederly. In: Shader RI, DiMascio A (eds) Psychotropic drug side effects. Williams & Wilkins, Baltimore

    Google Scholar 

  • Schatzberg AF, Cole JO (1991) Manual of clinical psychopharmacology, 2nd edn. American Psychiatric Press, Washington London

    Google Scholar 

  • Schifano F et al (1990) A double blind comparison of mianserin and maprotiline in depressed medically ill elderly people. Acta Psychiatr Scand 81: 289–294

    PubMed  CAS  Google Scholar 

  • Schöny W (1992) Die Wirksamkeit und Verträglichkeit von Citalopram im Vergleich von parenteraler und oraler Verabreichung. Neuropsychiatrie 6: 65–71

    Google Scholar 

  • Schöny W, Rittmannsberger H (1992) Praktische Durchführung, allgemeine Behandlungsrichtlinien. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuropsychoharmaka. Ein Therapiehandbuch. Bd 4: Neuroleptika. Springer, Wien New York, S 129–152

    Google Scholar 

  • Schuckit M, Robins E, Feighner J (1971) Tricyclic antidepressant and monoamine oxidase inhibitors. Combination therapy in the treatment of depression. Arch Gen Psychiatry 24: 509–514

    PubMed  CAS  Google Scholar 

  • Sepälla T, Stromberg C, Bergmann I (1984) Effects of zimeldine, mianserin and amitripty-line on psychomotor skills and their interaction with ethanol. Eur J Clin Pharmacol 27: 181–189

    Google Scholar 

  • Seppala M et al (1993) Midazolam and flunitraze-pam: pharmacocinetics and effects on night time respiration and body movements in the elderly. Int J Clin Pharmacol Ther Toxicol 31: 170–176

    PubMed  CAS  Google Scholar 

  • Shimizu M et al (1985) A multicentre, double-blind comparative study of tiapride and chlorpromazine in patients with psychiatric disorders of the aged (Translation from Japanese — Jap J Clinical Psychiatry) Rinsho Seishin Igaku 27: 573–582

    Google Scholar 

  • Shorr RI, Robin DW (1994) Rational use of benzodiazepines in the elderly. Drugs Aging 4: 9–20

    PubMed  CAS  Google Scholar 

  • Sizaret P, Walker SE, Mackenzie S (1974) Clinical investigation of lorazepam. Psychol Med 6: 591–598

    Google Scholar 

  • Smith DA, Perry PJ (1992) Non-neuroleptic treatment of disruptive behavior in organic mental syndromes. Ann Pharmacother 26: 1400–1408

    PubMed  CAS  Google Scholar 

  • Spiker DG, Pugh DD (1976) Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch Gen Psychiatry 33: 828–830

    PubMed  CAS  Google Scholar 

  • Steele JW, Faulds D, Sorkin EM (1993) Tiaprid: a review of ist pharmacodynamic and pharmacokinetic properties and therapeutic potential in geriatric agitation. Drugs & Aging 3: 460–478

    CAS  Google Scholar 

  • Steinberg JR (1994) Anxiety in elderly patients. A comparison of azaspirones and benzodiazepines. Drugs & Aging 5: 335–345

    CAS  Google Scholar 

  • Steiner W, Fontaine R (1986) Toxic reaction following the combined administration of fluoxetine and L-tryptophane: five case reports. Biol Psychiatry 21: 53–58

    Google Scholar 

  • Sternbach H (1988) Danger of MAOI therapy after fluoxetine withdrawal. Lancet, pp 850–851

    Google Scholar 

  • Stoeckel K, Pfefen JP, Mayersohn M (1990) Absorption and disposition of moclobemide in patients with advanced age or reduced liver and kidney function. Acta Psychiatr Scand 82 [Suppl 360]: 94–97

    Google Scholar 

  • Sutherland DL et al (1987) The influnece of cimetidine versus ranitidine on doxepin pharmacokinetics. J Clin Psychopharmacol 32: 159–164

    CAS  Google Scholar 

  • Swantek SS et al (1991) The use of carbamazepine to treat benzodiazepine withdrawal in a geriatric population. J Geriatr Psychiatry Neurol 4: 106–109

    PubMed  CAS  Google Scholar 

  • Vaughan DA (1988) Interaction of fluoxetine with tricyclic antidepressants. Am J Psychiatry 145: 1478

    PubMed  CAS  Google Scholar 

  • Vesell ES (1970) Impairment of drug metabolism in man by allopurinol and nortryptilyne. N Engl J Med 283: 1484

    PubMed  CAS  Google Scholar 

  • Watsky E, Salzman C (1992) Psychotropic drug dosage and drug interactions. In: Salzman C (ed) Clinical geriatric psychopharmacology, 2nd edn. Williams & Wilkins, Baltimore Tokyo, pp 303–331

    Google Scholar 

  • Weber E (1991) Taschenbuch der unerwünschten Arzneiwirkungen. Fischer, Stuttgart

    Google Scholar 

  • Weil C (1988) Hydergin, pharmakologische und klinische Befunde. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Weiss H (1989) Wirksamkeit des Gingko biloba Extraktes (EGb-76l) bei Hirnleistungsstörungen. Münch Med Wochenschr 131 [Beilage 82]: 6

    Google Scholar 

  • Wells BG, Gelenberg AJ (1981) Chemistry, pharmacology, pharmacokinetics, adverse effects and efficacy ofthe antidepressant ma-protiline hydrochloride. Pharmacotherapy 1: 121–142

    PubMed  CAS  Google Scholar 

  • Wester HA, Siegers CP (1980) Cardiovaskular effects of mianserin and amitriptyline in healthy volunteers. Curr Med Res Opin 6: 29–35

    CAS  Google Scholar 

  • Wood P, Castleden CM (1991) Psychopharma-cology in the elderly. In: Jacoby R, Oppen-heimer C (eds) Psychiatry in the elderly. Oxford University Press, Oxford New York Tokyo, pp 339–372

    Google Scholar 

  • Wragg RE, Jeste DV (1988) Neuroleptics and alternative treatments: management of behavioral symptoms and psychosis in Alzheimer’s disease and related conditions. Psychiatr Clin North Am 11: 195–213

    PubMed  CAS  Google Scholar 

  • Young RC, Meyers BS (1991) Psychopharmacology. In: Sadavoy LW, Jarvik LF (eds) Comprehensive review of geriatric psychiatry. American Psychiatric Press, Washington DC, pp 435–468

    Google Scholar 

  • Zimmer R et al (1990) Interaction studies with moclobemide. Acta Psychiatr Scand 82 [Suppl 360]: 84–86

    Google Scholar 

Download references

Authors
  1. Peter Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter K. Fischhof
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Georg Zapotoczky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik für Psychiatrie, Graz, Österreich

    Hans G. Zapotoczky  & Peter K. Fischhof  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Wien

About this chapter

Cite this chapter

Hofmann, P., Fischhof, P.K., Zapotoczky, H.G. (1996). Psychopharmakotherapie. In: Zapotoczky, H.G., Fischhof, P.K. (eds) Handbuch der Gerontopsychiatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6563-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6563-8_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7351-0

  • Online ISBN: 978-3-7091-6563-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation